If You Want to Roll the Dice on Ocugen Stock, Understand the Game You’re Playing

InvestorPlace2021-04-27

OCGN stock is another social media stock that has no reason to be where it is OK, let’s wrap our heads around this one:Ocugen (NASDAQ:OCGN) has a $1.4 billion market capitalization. But its entire ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

HLPA
2021-04-29
HLPA
11.40 and gaining support!
Yh1
2021-04-28
Yh1
Wah. Better get out before it is too late
- S土豪熊貓G:
  FDA news is coming soon.
S土豪熊貓G
2021-04-27
S土豪熊貓G
Ocugen if the stock to watch! Stock piling for more!
- lespritdefoi:
  ok
Puggysmall
2021-04-27
Puggysmall
Yolo degens lfg

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1168717328?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-04-27 16:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168717328","market":"us","top_or_hot":-1,"title":"If You Want to Roll the Dice on Ocugen Stock, Understand the Game You’re Playing","media":"InvestorPlace","content":"<div>\n<p>OCGN stock is another social media stock that has no reason to be where it is\nOK, let’s wrap our heads around this one:Ocugen (NASDAQ:OCGN) has a $1.4 billion market capitalization. But its entire ...</p>\n\n<a href=\"https://investorplace.com/2021/04/roll-dice-ocgn-stock-but-know-game-youre-playing/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If You Want to Roll the Dice on Ocugen Stock, Understand the Game You’re Playing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf You Want to Roll the Dice on Ocugen Stock, Understand the Game You’re Playing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-27 16:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/roll-dice-ocgn-stock-but-know-game-youre-playing/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>OCGN stock is another social media stock that has no reason to be where it is\nOK, let’s wrap our heads around this one:Ocugen (NASDAQ:OCGN) has a $1.4 billion market capitalization. But its entire ...</p>\n\n<a href=\"https://investorplace.com/2021/04/roll-dice-ocgn-stock-but-know-game-youre-playing/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCGN","symbol_name":"Ocugen","start_time":0,"source_url":"https://investorplace.com/2021/04/roll-dice-ocgn-stock-but-know-game-youre-playing/","article_id":"1168717328","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168717328","pubTimestamp":1619510618,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"OCGN stock is another social media stock that has no reason to be where it is\nOK, let’s wrap our hea","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"OCGN":"Ocugen"},"translate_title":"如果你想在Ocugen的股票上掷骰子，请理解你正在玩的游戏","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OCGN":0.9},"content_text":"OCGN stock is another social media stock that has no reason to be where it is\nOK, let’s wrap our heads around this one:Ocugen (NASDAQ:OCGN) has a $1.4 billion market capitalization. But its entire pipeline is still in preclinical trials for various ophthalmic conditions. And it’s been around for just over five years. What is going on with OCGN stock?\nA similar company in the space,EyePoint Pharmaceuticals (NASDAQ:EYPT) has been around for more than 30 years, has a drug on the market and was spun-off from a division of ophthalmic heavy-hitter Bausch & Lomb. It has a market cap of $278.5 million.\nWhat’s the difference?Reddit.Robinhood. And the fact that OCGN announced that it was the U.S. distributor of a Covid-19 vaccine that’s produced in India.\nLosing Sight of OCGN Stock\nThe question is, how did a company looking to cure eye diseases end up as a potential distribution partner for a Covid-19 vaccine?\nConnections, I suppose.\nBut then again, does it really matter?\nThe fact that people — and institutions — jumped into this stock and continue jumping into this stock is either amazing or amazingly depressing.\nFirst of all, this tiny ophthalmic company has no real distribution channels for the drug in the U.S. and isn’t big enough to dedicate staff to run a national distribution operation.\nIt’s not like they’re going to have this stuff dropped in a warehouse and then ship packages to pharmacy chains and hospitals. And they’re not going to drive it around in a delivery truck they rented. At least I hope that isn’t the plan.\nI don’t know because that level of detail isn’t important. I mean, even with 230 million Americans vaccinated and a growing surplus of the current approved vaccines, having another vaccine from a country in dire need of effective vaccines — in India, Covid-19 cases are spiking dramatically — isn’t a priority. At all.\nYet OCGN stock is up 533% year-to-date — 457% in the past three months.\nFOMO on Steroids\nThe trouble here is, new investors that have more money than market-savvy ones are buying into whatever cult stocks they see on their favorite social media channel. When it goes viral, these thinly traded stocks rise, and these investors think they’re onto something big.\nThen the short-sellers roll in and bet on the stock’s demise. When investors keep buying, they blow the short-sellers out and the ensuing “short squeeze” sends the stock even higher, further accelerating the cult stock’s status.\nBut all this is empty speculation. It’s fun, and if you know when to walk away, it can be lucrative. But it’s the gamification of investing, or should I say, trading. And OCGN stock is a poster child of social media investors with FOMO (fear of missing out).\nSteak 0, Sizzle 1\nDollars to doughnuts, OCGN stockholders aren’t in this for the company’s eye medications under development. As I noted previously, EYPT has been in this market for 30 years and has drugs on the market. And patents. And distribution deals. And it’s trading at aquarterof the valuation of OCGN, in this heady market.\nAlso bear in mind that ophthalmic drugs are notoriously difficult to make money on. An ophthalmologist once explained to me that Medicare doesn’t cover a lot of new eye meds because the calculation is, being blind isn’t fatal. So, Medicare supports drugs that help heart attacks, strokes and chronic conditions that can kill people.\nWhat’s more, OCGN isn’t going to have a drug on the market for years, even if trials go well. And this is a hotly competitive space, so it’s up against pricing and scale issues as well.\nSo, we’re left with all this being about an India-made Covid-19 vaccine distribution deal that isn’t even approved in India yet. And after Indian approval, it still has to get U.S. approval.\nRoll the dice if you like, just understand the game you’re playing.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":100429265,"gmtCreate":1619635623857,"gmtModify":1704727146040,"author":{"id":"3569274903458035","authorId":"3569274903458035","name":"HLPA","avatar":"https://static.tigerbbs.com/07e7b987a9127c5a47dbc3ae02db548b","vip":1,"hat":"https://static.tigerbbs.com/646756f1284a5a6480ed02cc4fa7d1d2","crmLevel":8,"crmLevelSwitch":1,"idStr":"3569274903458035","authorIdStr":"3569274903458035"},"htmlText":"11.40 and gaining support!","listText":"11.40 and gaining support!","text":"11.40 and gaining support!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/100429265","repostId":1168717328,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":377737334,"gmtCreate":1619565154528,"gmtModify":1704725874132,"author":{"id":"3558523389451047","authorId":"3558523389451047","name":"Yh1","avatar":"https://static.tigerbbs.com/2c577f92c97c37d7b33594dcf2b56891","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3558523389451047","authorIdStr":"3558523389451047"},"htmlText":"Wah. Better get out before it is too late","listText":"Wah. Better get out before it is too late","text":"Wah. Better get out before it is too late","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/377737334","repostId":1168717328,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4162166,"gmtCreate":1619620969310,"gmtModify":1680786040976,"authorId":3578811676095048,"author":{"id":3578811676095048,"idStr":"3578811676095048","authorId":3578811676095048,"name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":377737334,"type":1,"supId":0,"prevId":0,"content":"FDA news is coming soon. ","text":"FDA news is coming soon. ","html":"FDA news is coming soon. "}],"langContent":"EN"},{"id":377629511,"gmtCreate":1619525057733,"gmtModify":1704725378546,"author":{"id":"3578811676095048","authorId":"3578811676095048","name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3578811676095048","authorIdStr":"3578811676095048"},"htmlText":"Ocugen if the stock to watch! Stock piling for more!","listText":"Ocugen if the stock to watch! Stock piling for more!","text":"Ocugen if the stock to watch! Stock piling for more!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/377629511","repostId":1168717328,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4149987,"gmtCreate":1619526886336,"gmtModify":1680785850396,"authorId":3562546402152999,"author":{"id":3562546402152999,"idStr":"3562546402152999","authorId":3562546402152999,"name":"lespritdefoi","avatar":"https://static.tigerbbs.com/b50b8956405221845a9ae2b92f22d6ce","vip":1,"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":377629511,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"EN"},{"id":377853752,"gmtCreate":1619516895276,"gmtModify":1704725254728,"author":{"id":"3582020156086217","authorId":"3582020156086217","name":"Puggysmall","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":1,"crmLevelSwitch":0,"idStr":"3582020156086217","authorIdStr":"3582020156086217"},"htmlText":"Yolo degens lfg","listText":"Yolo degens lfg","text":"Yolo degens lfg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/377853752","repostId":1168717328,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":14,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1168717328"}